Literature DB >> 19468293

Inflammatory signaling: another drug target to improve glycemic control in type 2 diabetes.

Barry J Goldstein1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19468293      PMCID： PMC2635101          DOI： 10.1111/j.1752-8062.2008.00011.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN： 1752-8054            Impact factor:   4.689


× No keyword cloud information.
  10 in total

Review 1.  Inflammation and metabolic disorders.

Authors:  Gökhan S Hotamisligil
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

Review 2.  Global and societal implications of the diabetes epidemic.

Authors:  P Zimmet; K G Alberti; J Shaw
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

3.  IKK-beta links inflammation to obesity-induced insulin resistance.

Authors:  Melek C Arkan; Andrea L Hevener; Florian R Greten; Shin Maeda; Zhi-Wei Li; Jeffrey M Long; Anthony Wynshaw-Boris; Giuseppe Poli; Jerrold Olefsky; Michael Karin
Journal:  Nat Med       Date:  2005-01-30       Impact factor: 53.440

Review 4.  Type 2 diabetes: principles of pathogenesis and therapy.

Authors:  Michael Stumvoll; Barry J Goldstein; Timon W van Haeften
Journal:  Lancet       Date:  2005 Apr 9-15       Impact factor: 79.321

Review 5.  Type 2 diabetes--treat early, treat intensively.

Authors:  B J Goldstein; R Gomis; H-K Lee; L A Leiter
Journal:  Int J Clin Pract Suppl       Date:  2007-12

6.  Restoration of the acute insulin response by sodium salicylate. A glucose dose-related phenomenon.

Authors:  M Chen; R P Robertson
Journal:  Diabetes       Date:  1978-07       Impact factor: 9.461

Review 7.  Obesity, inflammation, and insulin resistance.

Authors:  Steven E Shoelson; Laura Herrero; Afia Naaz
Journal:  Gastroenterology       Date:  2007-05       Impact factor: 22.682

8.  Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  David M Nathan; John B Buse; Mayer B Davidson; Ele Ferrannini; Rury R Holman; Robert Sherwin; Bernard Zinman
Journal:  Diabetes Care       Date:  2008-01       Impact factor: 19.112

Review 9.  The biology of incretin hormones.

Authors:  Daniel J Drucker
Journal:  Cell Metab       Date:  2006-03       Impact factor: 27.287

10.  Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes.

Authors:  Allison B Goldfine; Robert Silver; Waleed Aldhahi; Dongsheng Cai; Elizabeth Tatro; Jongsoon Lee; Steven E Shoelson
Journal:  Clin Transl Sci       Date:  2008-05       Impact factor: 4.689
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.